The British Columbia Securities Commission is warning the public about Pegasus Pharmaceuticals Group Inc. (Pegasus) and its associated companies:

• Careseng Cancer Institute Inc. • Pegasus BioPark (Dalian) Co., Ltd.

Pegasus has been offering Pegasus bonds and debentures through its website (http://pegasusbonds.com) and sales agents. According to the company’s website, Pegasus is using the funds raised for cancer therapy clinics, new drug development and to upgrade manufacturing facilities.

The BCSC is concerned that Pegasus is offering these investments when it has not issued a prospectus or registered with the BCSC.  Furthermore, BCSC staff have concerns about the returns offered on the Pegasus investments, which are as high as 100% per annum.

The BCSC urges the public to be wary about investing in Pegasus or its associated companies.

The BCSC urges investors, agents, or members of the public who have been approached or have information about Pegasus Pharmaceuticals or any of its associated companies to contact the BCSC inquiries line at 604-899-6854 or 1-800-373-6393 (toll free).

Suggested Reading

Hedge funds beware

Elder Abuse Pt. 2: How are people approached?

CSA releases sixth annual Enforcement Report

More Resources

Enforcement Actions Instrumental in Deterring Financial Misconduct

The publication of this report in advance of Fraud Prevention Month helps Canadians to more easily identify fraudulent approaches and learn how to avoid them. Several fraud prevention tools and resources are available on the CSA’s website.

Long Weekend Back-to-School Shopping

In preparation for back-to-school shopping this year, prepare a list and a budget in advance and make sure you stay within its constraints.  In a recent survey, 8 in 10 Canadians believe that back-to-school shopping is getting more expensive. It is important to stay conscious of what your kids actually need for school and to […]